Developing new biopharmaceutical products for infectious diseases
Official title: Preclinical Services for Biopharmaceutical Product Development
Funded at University of Saskatchewan · NIH-10934791 · Data updated 2026-11-12
This study is working on improving the way new medicines, like antibodies and proteins, are developed to help treat infectious diseases, so that patients can have better and more effective treatment options.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Saskatchewan NIH-funded |
| Lab location | 1 site (Saskatoon, Canada) |
| Project start | September 8, 2023 |
| Project end | September 7, 2030 |
| Funding year | 2023 |
| Award (this year) | $1,023 |
| NIH project number | 75N93023D00013-0-759302300001-2 |
| Project ID | NIH-10934791 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals affected by infectious diseases who may benefit from novel biopharmaceutical therapies.
✕Less likely to help
Patients with non-infectious diseases or those not seeking new biopharmaceutical treatments may not receive any benefit from this research.
What this research studies
This research focuses on the preclinical development of biopharmaceutical products, including monoclonal antibodies, recombinant proteins, and small interfering RNA (siRNA) vectors. It aims to enhance the process of creating and evaluating these products through services like product development planning, assay development, and regulatory support. By advancing translational research, the project seeks to improve the development of treatments for infectious diseases, ultimately benefiting patients in need of innovative therapies.
Why it matters
Potential benefit: If successful, this research could lead to the development of new and effective treatments for infectious diseases.
How similar studies have gone: Other research in biopharmaceutical development has shown success in creating effective therapies, indicating that this approach has potential for positive outcomes.
Where this research is happening
-
University of Saskatchewan
Saskatoon, Canada Active
Related research
Other NIH-funded projects on the same topics.
-
Developing models to understand infectious diseases.
This study is working on building models that mimic infectious diseases to help scientists learn how they work and find better treatments, which could lead to improved options for patients dealing with these illnesses.
-
Developing models to understand infectious diseases.
This study is all about building models that mimic infectious diseases so researchers can learn how they work and find better treatments, which could help patients like you in the future.
-
Developing models to understand infectious diseases.
This study is all about building models that mimic infectious diseases so researchers can learn how they work and find better treatments, which could help patients like you in the future.
-
Developing new treatments to combat bacterial resistance using biopharmaceuticals
This study is working on new treatments to help fight stubborn bacterial infections that don't respond to regular antibiotics, so patients can have better options for getting better.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.